Elise Sverre
- Consultant; MD, PhD
- +47 990 20 329
Date of birth: 6. March 1979. Civil status: Married, one child. Nationality: Norwegian
Phone: +47 99020329 Email: elisbj@vestreviken.no
Home page NORCOR research group: https://norcor.no
Education
- MD, University of Oslo, 2006
- PhD, University of Oslo, 2015-2018
- Specialist in Internal Medicine (2016)
Work record
- Trainee in cardiology, Oslo University Hospital, Ullevål (2022-current)
- Post-doctoral fellow Dept. of Medicine, Drammen Hospital (2018-2022)
- Acting consultant in cardiology, Drammen Hospital (2011-2022)
- Resident, Internal Medicine and Cardiology, Drammen Hospital (2007-2011)
Memberships and other
- Professional member European Society of Cardiology (ESC), European Association for Preventive Cardiology (EAPC), Norwegian Society of Cardiology
- Co-chair of the NORCOR research group
- Teacher in clinical communication, University of Oslo (2019-2020)
Research areas
- Preventive cardiology
- Clinical pharmacology
- Cardiac intervention studies
- Behavioural medicine
Publications 2024
Statin discontinuation: How can we improve on the multiple pathways that contribute to suboptimal statin adherence?
Kardiol Pol (in press)
DOI 10.33963/v.phj.102335, PubMed 39240921
Treatment patterns and adherence to lipid-lowering drugs during eight-year follow-up after a coronary heart disease event
Atherosclerosis, 393, 117550
DOI 10.1016/j.atherosclerosis.2024.117550, PubMed 38657552
Validation of a novel direct method to determine reduced adherence to atorvastatin therapy
Eur Heart J Cardiovasc Pharmacother, 10 (4), 307-315
DOI 10.1093/ehjcvp/pvae001, PubMed 38196131
A multi-component intervention increased access to smoking cessation treatment after hospitalization for atherosclerotic cardiovascular disease: a randomized trial
Eur Heart J Open, 4 (2), oeae028
DOI 10.1093/ehjopen/oeae028, PubMed 38666249
Publications 2023
Psychiatric disorders, rumination, and metacognitions in patients with type D personality and coronary heart disease
Nord J Psychiatry, 77 (6), 540-546
DOI 10.1080/08039488.2023.2182358, PubMed 37079379
Predictors of health-related quality of life in outpatients with coronary heart disease
Front Psychol, 14, 1119093
DOI 10.3389/fpsyg.2023.1119093, PubMed 37359852
Atorvastatin Metabolite Pattern in Skeletal Muscle and Blood from Patients with Coronary Heart Disease and Statin-Associated Muscle Symptoms
Clin Pharmacol Ther, 113 (4), 887-895
DOI 10.1002/cpt.2844, PubMed 36622792
Frailty, health literacy and self-care in patients admitted with acute heart failure
Tidsskr Nor Laegeforen, 143 (17)
DOI 10.4045/tidsskr.23.0297, PubMed 37987080
[E. Sverre et al. respond]
Tidsskr Nor Laegeforen, 143 (3)
DOI 10.4045/tidsskr.23.0062, PubMed 36811436
Publications 2022
Insomnia as a predictor of recurrent cardiovascular events in patients with coronary heart disease
Sleep Adv, 3 (1), zpac007
DOI 10.1093/sleepadvances/zpac007, PubMed 37193392
Worry and rumination predict insomnia in patients with coronary heart disease: a cross-sectional study with long-term follow-up
J Clin Sleep Med, 18 (3), 779-787
DOI 10.5664/jcsm.9712, PubMed 34633284
Statins seldom cause adverse reactions
Tidsskr Nor Laegeforen, 142 (2)
DOI 10.4045/tidsskr.21.0885, PubMed 35107944
Personalised cardiovascular disease prevention in the new guidelines
Tidsskr Nor Laegeforen, 142 (17)
DOI 10.4045/tidsskr.22.0508, PubMed 36416647
Tailored clinical management after blinded statin challenge improved the lipid control in coronary patients with self-perceived muscle side effects
J Intern Med, 291 (6), 891-893
DOI 10.1111/joim.13454, PubMed 35103360
Publications 2021
Insomnia in patients with coronary heart disease: prevalence and correlates
J Clin Sleep Med, 17 (5), 931-938
DOI 10.5664/jcsm.9082, PubMed 33399066
The relationship between directly measured statin adherence, self-reported adherence measures and cholesterol levels in patients with coronary heart disease
Atherosclerosis, 336, 23-29
DOI 10.1016/j.atherosclerosis.2021.09.020, PubMed 34610521
Effect of atorvastatin on muscle symptoms in coronary heart disease patients with self-perceived statin muscle side effects: a randomized, double-blinded crossover trial
Eur Heart J Cardiovasc Pharmacother, 7 (6), 507-516
DOI 10.1093/ehjcvp/pvaa076, PubMed 32609361
Is the novel LDL-cholesterol goal <1.4 mmol/L achievable without a PCSK9 inhibitor in a chronic coronary population from clinical practice?
Eur J Prev Cardiol, 28 (8), e10-e11
DOI 10.1177/2047487320923187, PubMed 33611511
Post-myocardial infarction rehabilitation and secondary prevention in hospitals
Tidsskr Nor Laegeforen, 141 (16)
DOI 10.4045/tidsskr.21.0349, PubMed 34758605
Post-myocardial infarction rehabilitation and secondary prevention in hospitals
Tidsskr. Nor. Laegeforen., 141 (16), 1523-1526
Clinical and psychological factors in coronary heart disease patients with statin associated muscle side-effects
BMC Cardiovasc Disord, 21 (1), 596
DOI 10.1186/s12872-021-02422-7, PubMed 34915854
Publications 2020
Medical and Psychosocial Factors Associated With Low Physical Activity and Increasing Exercise Level After a Coronary Event
J Cardiopulm Rehabil Prev, 40 (1), 35-40
DOI 10.1097/HCR.0000000000000399, PubMed 30720643
Publications 2018
The follow-up after myocardial infarction - is it good enough?
Tidsskr Nor Laegeforen, 138 (5)
DOI 10.4045/tidsskr.17.1050, PubMed 29513442
The follow-up after myocardial infarction- is it good enough?
Tidsskr. Nor. Laegeforen., 138 (5), 434-437
Publications 2017
Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients
Eur J Prev Cardiol, 24 (9), 981-989
DOI 10.1177/2047487317693134, PubMed 28196429
Medical and sociodemographic factors predict persistent smoking after coronary events
BMC Cardiovasc Disord, 17 (1), 241
DOI 10.1186/s12872-017-0676-1, PubMed 28877684
Unfavourable risk factor control after coronary events in routine clinical practice
BMC Cardiovasc Disord, 17 (1), 40
DOI 10.1186/s12872-016-0387-z, PubMed 28109259
Optimal blood pressure control after coronary events: the challenge remains
J Am Soc Hypertens, 11 (12), 823-830
DOI 10.1016/j.jash.2017.10.007, PubMed 29128603
Publications 2016
Patient characteristics and risk factors of participants and non-participants in the NOR-COR study
Scand Cardiovasc J, 50 (5-6), 317-322
DOI 10.1080/14017431.2016.1202445, PubMed 27323914
Publications 2015
The role of medical and psychosocial factors for unfavourable coronary risk factor control
Scand Cardiovasc J, 50 (1), 1-8
DOI 10.3109/14017431.2015.1111408, PubMed 26488672